|
VRNA
|
Verona Pharma plc
|
0.14%
|
US
|
NASDAQ
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
0.14%
|
US
|
NASDAQ
|
|
RCKT
|
Rocket Pharmaceuticals, Inc.
|
0.14%
|
US
|
NASDAQ
|
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
0.14%
|
US
|
NASDAQ
|
|
TWST
|
Twist Bioscience Corporation
|
0.13%
|
US
|
NASDAQ
|
|
RXRX
|
Recursion Pharmaceuticals, Inc.
|
0.13%
|
US
|
NASDAQ
|
|
IMCR
|
Immunocore Holdings plc
|
0.13%
|
US
|
NASDAQ
|
|
AMPH
|
Amphastar Pharmaceuticals, Inc.
|
0.13%
|
US
|
NASDAQ
|
|
TVTX
|
Travere Therapeutics, Inc.
|
0.12%
|
US
|
NASDAQ
|
|
REPL
|
Replimune Group, Inc.
|
0.12%
|
US
|
NASDAQ
|
|
MYGN
|
Myriad Genetics, Inc.
|
0.12%
|
US
|
NASDAQ
|
|
MNKD
|
MannKind Corporation
|
0.12%
|
US
|
NASDAQ
|
|
ZNTL
|
Zentalis Pharmaceuticals, Inc.
|
0.11%
|
US
|
NASDAQ
|
|
ADPT
|
Adaptive Biotechnologies Corporation
|
0.11%
|
US
|
NASDAQ
|
|
RETA
|
Reata Pharmaceuticals, Inc. - Class A
|
0.10%
|
US
|
NASDAQ
|
|
QURE
|
uniQure N.V.
|
0.10%
|
US
|
NASDAQ
|
|
MORF
|
Morphic Holding, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
0.10%
|
US
|
NASDAQ
|
|
ENTA
|
Enanta Pharmaceuticals, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
BBIO
|
BridgeBio Pharma, Inc.
|
0.10%
|
US
|
NASDAQ
|